Abstracts of the 9th Congress of the
European Society of Contraception
|
|||
|
3-6 MAY 2006 ISTANBUL/ TURKEY |
|||
| Free communications
hormonal contraception for men |
Presentations | Abstracts | |
| A group of university male students’
approach towards unwanted pregnancy |
A. Akin (Turkey) | powerpoint | Abstract |
| Male participation in modern
contraception methods using |
S. Djalalinia (Iran) | Abstract | |
Session 1
Implanon Is it cost effective? An Audit
of the Use of Implanon in East and North Hertfordshire.
J.Seres (UK)
Men who pay for sex…Do partners need
protecting?
T.M. Groom (UK)
Male sexual dysfunction among
applicants for vasectomy
B. Dilbaz (Turkey)
Effectively Managing a Nurse-Led
Chlamydia Screening Programme In England.
S. J. Lavelle (UK)
Establishing Reproductive Health
Education And Counseling In Military Services: The Turkish Model
S. Gungor (Turkey)
Peer Education of Reproductive Health
among Youth
F. Ramezanitehrani (Iran)
Postgraduate students’ attitudes
towards parenthood and their awareness concerning fertility; are there
any differences between females and males?
T.A. Tydén (Sweden)
medical abortion
Is there an optimum time interval from
vaginal misoprostol administration to surgical abortion?
A.K. Banerjee (UK)
Abortion in Europe: are the laws and
practices patient centred?
C. Fiala (Austria)
Session 2
Silverlily and Goldlily IUDs: do alloys
create a new generation of intrauterine contraceptive devices?
I. Batar (Hungary)
Contraception Again with IUD After IUD
Dislocation and IUD+pregnancy (evaluation of 6412 cases)
M.M. Inal (Turkey)
Intrauterine devices 22 years of
experience
I. Mattos (Spain)
Study of intrauterine device insertions
and clinical performance in nulliparous women
A. Brockmeyer (UK)
The contraceptive vaginal ring compared
with the pill in RCT’s
F.J.M.E. Roumen (The Netherlands)
Continuous LNG/EE, a low-dose
continuous-use oral contraceptive, provides similar efficacy and safety
to a monthly cyclic oral contraceptive.
A. Teichmann (Germany)
A multicentred phase IV comparative
study between two implantable contraceptives containing levonorgestrel (Jadelle®
and Norplant®) on Indonesian women
B. Affandi (Indonesia)
pharmacokinetics of hormones
Estrogen levels and genitourinary signs
and symptoms during DMPA use
E.Z. Tuzcular Vural (Turkey)
Bone mineral density in users of two
kinds of once-a-month combined injectable contraceptives
C.R.T. Juliato (Brazil)
Session 3
A comprehensive study of the effects of
medroxyprogesterone acetate, levonorgestrel, and norethindrone on
endometrial cells using proteomics and genomic analysis
S. Mirkin (USA)
Comparison of perspectives in women and
men about side effects of contraceptions in Iran
F. Hejazi (Iran)
Have clients aged over 40 on
Depo-Provera (DMPA) attending our Community Contraception and Sexual
Health Clinic (CASH) had a documented discussion on ‘bone health’ in
the last two years?
N. Mullin (UK)
Contraceptive use patterns among 9394
women applying to a metropolitan FP center in Turkey
B. Dilbaz (Turkey)
Characteristics of Teenage Abortion in
Southern China
D. Yang (China)
Differential genomic and proteomic
profi les of synthetics progestins in the breast
S. Mirkin (USA)
Fertility regulation in women with different religious
beliefs in R. Macedonia
D. Tanturovski (Macedonia)
attitudes to contraception
University student men’s views,
attitudes and behaviours about family planning and emergency
contraception
H. Sahin (Turkey)
Reproductive Health Education of
Conscripts Armed Forces: First Evaluation of Training Courses.
S. Gungor (Turkey)
Session 4
The Challenges of Unprotected Sex:
Statistical Analysis of a Global Sex Survey
M.B.F. Fontes (USA)
Significant improvement in
cycle-related symptoms following treatment with continuous LNG/EE, a
low-dose continuous oral contraceptive.
E.W. Freeman (USA)
Prevalence of bacterial vaginosis and
relationship with personal hygiene in Turkish women using an IUD
I. Gonenc (Turkey)
Identification of novel endometrial
targets for contraception using microarray technology
S. Mirkin (USA)
Evaluation of the benefi ts of a new
hysteroscopic sterilisation (Essure®) on the OPD.
M.P.H. Vleugels (The Netherlands)
Ease and safety of insertion,
contraceptive performance and effect on menstrual blood loss of a new
LNG-IUS, FemilisTM, in parous and nulliparous women
D. Wildemeersch (Belgium)
The poor knowledge on contraceptive
methods is major cause of induced abortion leading to infectious
abortion in women of west areas in Iran
R. Ahmadi (Iran)
communications considerations in adolescence
Teenage mothers – a high risk group for
new unintended pregnancies.
G. Falk (Sweden)
Adolescent Sexual Behaviour: Healthy
Trends and Two Disturbing Findings
G.C. Hess (Canada)
communications good clinical practice
Screening for Neisseria Gonorrhoea
within a Chlamydia Screening Programme in England – results from the
first 18 months
SJ Lavelle (UK)
Enhancing clients’ experience:
Reducing waiting times through use of Computerised Patient-Flow Analysis
in a Fertility Control Clinic
B.A. Gbolade (UK)
communications sexual life
Meeting demand for comprehensive sexual
health needs: the experience within a primary care setting in the UK.
D. Lee (UK)
The rate of re-infection within a major
city community based chlamydia screening programme
A. Taylor (UK)